IL6 and breast carcinoma: This hypothesis aligns with Ahmad et al.‘s proposition that the simultaneous expression of IL6 and IL10 in tumor tissues improves the survival of breast cancer patients, although underlying mechanisms remain unclear (Ahmad et al., 2018).